Steven Cohen’s Alto Neuroscience ANRO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANRO
Steven Cohen's ANRO Position: Q3 2026 in Review
Steven Cohen increased its Alto Neuroscience (ANRO) stake by 15% in Q3 2026, buying an estimated $2.21M and bringing the position to 576,375 shares worth $14.7M. The position accounts for 0.02% of the portfolio, ranked #1102.
Steven Cohen first reported a position in ANRO in Q1 2024 and has held it in 11 quarters since. The position peaked at $28.6M in Q4 2025. 131 funds tracked by Wall St. Rank hold ANRO as of Q3 2026.
- Steven Cohen held 576,375 shares of Alto Neuroscience worth $14.7M as of Q3 2026.
- Steven Cohen bought 73,425 Alto Neuroscience shares in Q3 2026, an estimated $2.21M.
- Alto Neuroscience made up 0.02% of Steven Cohen's portfolio in Q3 2026, its #1102 holding.
- Steven Cohen first reported a position in Alto Neuroscience in Q1 2024 and has held it in 11 quarters since.
- Steven Cohen's Alto Neuroscience position peaked at $28.6M in Q4 2025.
- 131 funds tracked by Wall St. Rank held Alto Neuroscience as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.